Comprehensive patient-level classification and quantification of driver events in TCGA PanCanAtlas cohorts.
There is a growing need to develop novel therapeutics for targeted treatment of cancer.The prerequisite to doorking 1835-080 success is the knowledge about which types of molecular alterations are predominantly driving tumorigenesis.To shed light onto this subject, we have utilized the largest database of human cancer mutations-TCGA PanCanAtlas, mu